From The Matrix to tangled wizard wars, these trilogies buried great ideas under lore, retcons, and endless explanations.

In the mood for 'The Matrix Reloaded' at home? Here’s where you can watch it, including platforms and services with rental, purchase, and subscription options, all in one place. In the US, you can ...

Pedro Barata is joined by Kathryn Beckermann to discuss the KEYMAKER-U03 trial. This phase I/II umbrella platform study evaluates combinations in refractory clear-cell kidney cancer patients who ...

The right gear can make all the difference in Marathon. And if you know how the Armory refresh system works, you’ll always have easy access to meds, shields, weapons, and more. Here are all the ...

Investigators sought to determine if adding favezelimab or vibostolimab to enfortumab vedotin/pembrolizumab improved overall response rates in patients with locally advanced or metastatic carcinoma.

Daiichi Sankyo Company ((DSKYF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

First-line triplet therapy may expand clinical benefit for advanced clear cell renal cell carcinoma (ccRCC). The phase Ib/II KEYMAKER-U03 Substudy 03A (NCT04626479) investigated novel pembrolizumab ...

KEYMAKER-U03 is an international, multicenter, open-label, Phase I/II umbrella trial evaluating experimental combinations of pembrolizumab-based immunotherapy and targeted treatments for advanced ...

Belzutifan, pembrolizumab, and lenvatinib combination showed improved efficacy in advanced ccRCC compared with other regimens. Arm 4 demonstrated a significant median duration of response and ...